Enable Biosciences wins Amgen Golden Ticket Award, free lab, and office space for a year.

July 11, 2017

Enable Biosciences nabs top award in Amgen's annual Golden Ticket competition. Along with co-awardee Darmiyan, Enable will receive up to a year of free office and lab space in the prestigious QB3@953 biotech incubator space.

Read More


Enable Biosciences co-founder, Carolyn Bertozzi, wins top Organic Chemistry Prize given by American Chemical Society.

May 30, 2017

Professor Carolyn Bertozzi, PhD, co-founder and chair of Enable’s Scientific Advisory board, has received the 2017 ACS Arthur C. Cope prize. The award is the highest honor given to an organic chemist by the American Chemical Society.

Read More


Enable Biosciences one of six companies selected to pitch at annual StartOut Demo Day.

May 11, 2017

StartOut is the premiere LGBT entrepreneurship organization. Attendees will get a first look at the startups, meet the founders, and network with other top-tier investors, corporate strategists & press.

Read More


Enable Biosciences CSO presents at ACS 2017 in San Francisco on Entrepreneurial Opportunities in Chemistry

April 3, 2017

Are you attending the ACS National Meeting this weekend? Come to the Entrepreneurial Opportunities in Chemistry symposium and learn more about what it to takes to run and work for a startup.

Read More


Enable Biosciences admitted to prestigious I-Corps program through NIH,
National Science Foundation.

March 13, 2017

Enable Biosciences began the 8-week I-Corps program with a kickoff meeting in Washington, DC. Enable will receive $50,000 in supplemental funds to aid in business development and customer discovery.

Read More


Enable Biosciences CEO Dr. David Seftel and CSO Dr. Peter Robinson present at the
Amgen Innovator Series.

Feb 22, 2017

Enable Biosciences presented “Enabling Awesome: Bootstrapping a Diagnostic from Idea to Industry” as a part of the
Amgen Innovator Series at QB3.

Read More


Enable Biosciences joins acclaimed StartX accelerator;
pitches at 2017 Demo Day.

Dec 31, 2016

StartX is a Stanford-affiliated non-profit accelerator program that connects and cultivates founders, mentors, and advisors by providing $600k+ of free resources and access to the StartX fund.

Read More


Enable Biosciences CEO, Dr. David Seftel, MD/MBA profiled in the San Francisco Chronicle.

Dec 31, 2016

Standing up for the little guy, the underdog, comes naturally for Seftel. It’s in his genes. He was born in South Africa during the height of apartheid. His parents were physicians and social activists, and friends of Nelson Mandela.

Read More


Glu, a type 1 diabetes online community, interviews Enable Biosciences CEO,
Dr. David Seftel, MD/MBA.

Dec 13, 2016

An early diagnosis is one of the most important tools available to manage type 1 diabetes (T1D). Addressing this need is the first place winner in the late-stage projects of the 2016 Diabetes Innovation Challenges, Enable Biosciences of San Francisco, CA.

Read More


Enable Biosciences wins $150,000 with First-Place Finish at Inaugural Diabetes Innovation Challenge.

Oct 22, 2016

We won! Enable Biosciences captures the top prize in the first-ever Diabetes Innovation Challenge. We will receive up to $150,000 in cash and in-kind services to help us accelerate the development of our ultrasensitive and low-cost antibody tests for type 1 diabetes.

Read More


Enable Biosciences’ advances to Semi-Finals of Diabetes Innovation Challenge, competes for shot at $150,000 prize.

Oct 12, 2016

On September 29, Enable Biosciences’ CSO and co-founder Peter Robinson competed in the Semi-Finals of the Diabetes Innovation Challenge in Worcester, Massachusetts at the University of Massachusetts Medical School. The Challenge is sponsored by the T1D Exchange and M2D2, in addition to numerous other sponsors, such as the JDRF and the American Diabetes Association.

Read More


Enable Biosciences’ co-founder Carolyn Bertozzi wins top Organic Chemistry award from the American Chemical Society.

August 25, 2016

Carolyn Bertozzi, chair of the scientific advisory board and co-founder of Enable Biosciences, has received the 2017 ACS Arthur C. Cope award, the premier prize for achievement in Organic Chemistry awarded by the American Chemical Society. Congratulations Carolyn!


Enable Biosciences is highlighted in GenomeWeb “lifting the veil” article.

August 25, 2016

Check out the article: “Startup Enable Biosciences Wins SBIR Funds to Commercialize PCR-Based Antibody Detection”.


Enable Biosciences secures $225k from the National Science Foundation to develop biomarker discovery platform.

July 18, 2016

Enable Biosciences received $225,000 from the National Science Foundation to create a supermultiplexed panel for autoantibody screening using their proprietary ADAP technology. The technology platform will be developed in collaboration with physicians and scientists at Stanford School of Medicine.


Enable Biosciences receives $225k from the NIH to develop ultrasensitive diagnostics for Type 1 Diabetes.

July 18, 2016

The NIH and NIDDK report that Enable Biosciences is set to receive $225,000 through their Small Business Innovative Research grant program to develop an ultrasensitive testing platform for detecting early-stage type 1 diabetes. Enable Biosciences’ ADAP technology is 1000-10000 times more sensitive than current type 1 diabetes diagnostic technologies and can be performed near or at the point of care. This work will be completed in collaboration with investigators affiliated with UCSF’s Madison Clinic for Pediatric Diabetes.